Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease
- PMID: 20043104
Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease
Abstract
The synucleins (alpha-, beta- and gamma-synuclein) are a small, soluble, highly conserved group of neuronal proteins that attracted considerable attention due to their involvement in both neurodegenerative diseases and cancer. In this study, we examined the synuclein exprsssion in colorectal cancer (CRC) tissues, tumor-matched non-neoplastic adjacent tissues (NNAT), and CRC cell lines, and then investigated clinical significance of synucleins. By using semi-quantitative RT-PCR, synuclein mRNA expression was detected in eight CRC cell lines. It was much higher in CRC samples than in NNAT samples (P<0.05). The results of western blotting showed that the levels of synucleins protein expression in CRC cells approximately corresponded to the levels of synuclein mRNA expression. Immunohistochemical staining revealed that gamma-synuclein protein expression was up-regulated in CRC samples compared to NNAT samples (P=0.022), and was significantly correlated with clinical stage and lymph node involvement of CRC (P<0.05). Although, there was no significant difference in either alpha- or beta-synuclein protein expression between tumor and normal samples (P>0.05), often more than one form of synuclein was expressed in a tumor sample. More ratios of later stage and lymph node-positive tumors expressed a least one type of synuclein protein, and more ratios showed positive for either alpha or gamma-synuclein expression, as well as positive either for beta or gamma-synuclein in more ratios of lymph node-positive tumors. These results show that alpha-, beta- and gamma-synuclein are expressed in a high percentage of CRC. gamma-synuclein protein is valuable for evaluation of progression of CRC, and it is more sensitive to predict advanced stage and lymph node invasion by detection of gamma-synuclein protein combined with either alpha- or beta-synuclein protein or both than by detection of gamma-synuclein only.
Similar articles
-
Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.Cancer. 2000 May 1;88(9):2154-63. Cancer. 2000. PMID: 10813729
-
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.Breast Cancer Res Treat. 2007 Mar;101(3):259-67. doi: 10.1007/s10549-006-9296-7. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821081
-
The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.Neuro Endocrinol Lett. 2006 Jun;27(3):381-6. Neuro Endocrinol Lett. 2006. PMID: 16816827
-
Gamma-synuclein and the progression of cancer.FASEB J. 2007 Nov;21(13):3419-30. doi: 10.1096/fj.07-8379rev. Epub 2007 Jun 12. FASEB J. 2007. PMID: 17567567 Review.
-
Fish Synucleins: An Update.Mar Drugs. 2015 Oct 30;13(11):6665-86. doi: 10.3390/md13116665. Mar Drugs. 2015. PMID: 26528989 Free PMC article. Review.
Cited by
-
α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease.PLoS One. 2011;6(5):e19622. doi: 10.1371/journal.pone.0019622. Epub 2011 May 18. PLoS One. 2011. PMID: 21611169 Free PMC article.
-
Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.Int J Mol Sci. 2024 Mar 31;25(7):3899. doi: 10.3390/ijms25073899. Int J Mol Sci. 2024. PMID: 38612708 Free PMC article. Review.
-
Prognostic significance of SNCA and its methylation in bladder cancer.BMC Cancer. 2022 Mar 26;22(1):330. doi: 10.1186/s12885-022-09411-9. BMC Cancer. 2022. PMID: 35346107 Free PMC article.
-
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.Neurol Sci. 2017 Jan;38(1):171-179. doi: 10.1007/s10072-016-2745-0. Epub 2016 Nov 1. Neurol Sci. 2017. PMID: 27803984
-
Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity.Cancers (Basel). 2022 Mar 8;14(6):1382. doi: 10.3390/cancers14061382. Cancers (Basel). 2022. PMID: 35326535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials